Has Regeneron Stock Quietly Become A Value Buy?

REGN stock is presently trading nearly 38% lower than its 1-year peak, and is also being traded at a P/S multiple that is ...
Investor's Business Daily on MSN

Sanofi Jumps As Dupixent Nears $5 Billion In Sales; Trump Drug Talks Continue

Sanofi stock jumped early Friday on better-than-expected third-quarter sales and earnings, and a strong showing from Dupixent ...
Devdiscourse

Reuters Health News Summary

The regulator said it has selected Merck KGaA's fertility drug Pergoveris, Sanofi's Type 1 diabetes drug teplizumab, Regeneron's DB-OTO for deafness and ketamine for domestic manufacturing of a ...